JP2017525655A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017525655A5 JP2017525655A5 JP2016570807A JP2016570807A JP2017525655A5 JP 2017525655 A5 JP2017525655 A5 JP 2017525655A5 JP 2016570807 A JP2016570807 A JP 2016570807A JP 2016570807 A JP2016570807 A JP 2016570807A JP 2017525655 A5 JP2017525655 A5 JP 2017525655A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- dectin
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462006575P | 2014-06-02 | 2014-06-02 | |
| US62/006,575 | 2014-06-02 | ||
| PCT/US2015/033696 WO2015187637A1 (en) | 2014-06-02 | 2015-06-02 | Methods and compositions for treating allergy and inflammatory diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017525655A JP2017525655A (ja) | 2017-09-07 |
| JP2017525655A5 true JP2017525655A5 (enExample) | 2018-07-12 |
Family
ID=54767263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016570807A Pending JP2017525655A (ja) | 2014-06-02 | 2015-06-02 | アレルギーおよび炎症性疾患を治療するための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20170095573A1 (enExample) |
| EP (1) | EP3148575B1 (enExample) |
| JP (1) | JP2017525655A (enExample) |
| CN (1) | CN106456736A (enExample) |
| AU (1) | AU2015270845B2 (enExample) |
| CA (1) | CA2950293A1 (enExample) |
| IL (1) | IL249098A0 (enExample) |
| WO (1) | WO2015187637A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11135223B2 (en) * | 2016-01-22 | 2021-10-05 | Yale University | Compositions and methods for inhibiting Dkk-1 |
| KR102590454B1 (ko) | 2016-07-07 | 2023-10-17 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 항체-애쥬번트 접합체 |
| US11007256B2 (en) | 2016-09-26 | 2021-05-18 | The University Of Toledo | Synthetic lipopeptide vaccines and immunotherapeutics |
| CN110290810A (zh) * | 2016-12-13 | 2019-09-27 | 博尔特生物治疗药物有限公司 | 抗体佐剂缀合物 |
| BR112019022912A2 (pt) * | 2017-05-05 | 2020-05-26 | Allakos Inc. | Métodos e composições para tratar doenças oculares alérgicas |
| CA3067146A1 (en) * | 2017-06-28 | 2019-01-03 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for dectin-2 stimulation and cancer immunotherapy |
| JP2022525594A (ja) | 2019-03-15 | 2022-05-18 | ボルト バイオセラピューティクス、インコーポレーテッド | Ｈｅｒ２を標的とする免疫結合体 |
| US11744874B2 (en) | 2019-12-20 | 2023-09-05 | Nammi Therapeutics, Inc. | Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof |
| WO2021178818A2 (en) * | 2020-03-06 | 2021-09-10 | Beijing Xuanyi Pharmasciences Co., Ltd. | Therapeutic agents and conjugates thereof |
| US20230338590A1 (en) * | 2020-06-15 | 2023-10-26 | Monopar Therapeutics, Inc. | Materials and methods for treating coronavirus |
| CN112480244A (zh) * | 2020-11-24 | 2021-03-12 | 华科同济干细胞基因工程有限公司 | 一种抗过敏性纳米抗体组合物、抗体测定方法及喷雾剂 |
| US20240358822A1 (en) * | 2021-08-31 | 2024-10-31 | Ena Respiratory Pty Ltd | Allergy treatment |
| US20250223364A1 (en) * | 2022-04-04 | 2025-07-10 | Dren Bio, Inc. | Multispecific binding proteins that bind dectin-1 and cd20 and methods of use thereof |
| CN117426352B (zh) * | 2023-12-08 | 2024-03-08 | 中国中医科学院中药研究所 | 一种间质性肺病变动物模型的构建方法与应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101679949B (zh) * | 2007-02-23 | 2015-08-19 | 贝勒研究院 | 通过dectin-1激活人抗原呈递细胞的治疗性应用 |
| AU2010229835B2 (en) * | 2009-03-25 | 2015-01-15 | The Board Of Regents Of The University Of Texas System | Compositions for stimulation of mammalian innate immune resistance to pathogens |
| MX2012012833A (es) * | 2010-05-07 | 2012-11-30 | Baylor Res Inst | Cebado cruzado de celulas t cd8 positivas humanos moderada por inmunoreceptores de celulas dendriticas (dcir). |
| RU2013110889A (ru) * | 2010-08-13 | 2014-09-20 | Бейлор Рисёч Инститьют | Новые вакцинные адъюванты на основе адъювантов-антител, нацеливающих непосредственно на антигенпрезентирующие клетки |
| RU2016118628A (ru) * | 2010-10-01 | 2018-11-02 | Вентиркс Фармасьютикалз, Инк. | Способы лечения аллергических заболеваний |
| US20120128710A1 (en) * | 2010-11-02 | 2012-05-24 | Baylor Research Institute | Enhancement of Pathogen-Specific Memory Th17 Cell Responses |
| WO2012122396A1 (en) * | 2011-03-08 | 2012-09-13 | Baylor Research Institute | Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells |
| CA2840996A1 (en) * | 2011-07-11 | 2013-01-17 | Sourcebooks, Inc. | Customizable and interactive book system |
| WO2013033104A1 (en) * | 2011-08-29 | 2013-03-07 | Baylor Research Institute | CONTROLLING ALLERGY AND ASTHMA BY ACTIVATING HUMAN DCs VIA DECTIN-1 OR DECTIN-1 AND TOLL-LIKE RECEPTOR 2 (TLR2) |
| EP2659907A1 (en) * | 2012-05-01 | 2013-11-06 | Affiris AG | Compositions |
-
2015
- 2015-06-02 CA CA2950293A patent/CA2950293A1/en not_active Abandoned
- 2015-06-02 EP EP15803012.2A patent/EP3148575B1/en active Active
- 2015-06-02 WO PCT/US2015/033696 patent/WO2015187637A1/en not_active Ceased
- 2015-06-02 CN CN201580033187.8A patent/CN106456736A/zh active Pending
- 2015-06-02 US US15/316,040 patent/US20170095573A1/en not_active Abandoned
- 2015-06-02 JP JP2016570807A patent/JP2017525655A/ja active Pending
- 2015-06-02 AU AU2015270845A patent/AU2015270845B2/en not_active Ceased
-
2016
- 2016-11-21 IL IL249098A patent/IL249098A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7303126B2 (ja) | 抗ｂｃｍａ重鎖のみ抗体 | |
| JP7240335B2 (ja) | 抗ｂｃｍａ重鎖のみ抗体 | |
| JP7254699B2 (ja) | 抗ｂｃｍａ重鎖のみ抗体 | |
| JP7437325B2 (ja) | Ｉｌ－１１ｒａ抗体 | |
| US8921526B2 (en) | Mutated anti-TNFα antibodies and methods of their use | |
| TWI679019B (zh) | 抗ｉｌ－４／抗ｉｌ－１３之雙特異性抗體調配物 | |
| CA3039232C (en) | Anti-il-33 antibodies and uses thereof | |
| KR20170002645A (ko) | 개선된 면역글로불린 가변 도메인 | |
| US10479830B2 (en) | Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines | |
| TW201620933A (zh) | 抗體－飛諾莫接合物 | |
| JP2021520825A (ja) | ガレクチン−１０抗体 | |
| WO2015191934A2 (en) | Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases | |
| WO2021143826A1 (zh) | 重组抗程序性死亡受体1和抗分化抗原簇137双特异性抗体制剂及其用途 | |
| CN107206075A (zh) | 用cd154抗体治疗自身免疫性疾病 | |
| KR20140145959A (ko) | Ｒａｎｋｌ 결합 펩티드를 이용한 골 재흡수 억제 | |
| JP2022534433A (ja) | 抗ｇａｌ９免疫阻害性結合分子 | |
| KR20230010239A (ko) | 항-il-33 항체의 제형물 | |
| CN113614107A (zh) | Cd31竞争剂及其用途 | |
| US12509529B2 (en) | Antibodies and antibody fragments that bind IgE | |
| US20260139033A1 (en) | Tslp inhibitors and methods of use thereof | |
| KR102962504B1 (ko) | Il-5에 대한 항체를 함유하는 약학적 조성물 및 이의 용도 | |
| WO2025255340A2 (en) | BINDING PROTEINS THAT TARGET aC1s, TfR, OR BOTH, AND COMPOSITIONS THEREOF | |
| CN117866092A (zh) | 抗人cd73抗体或其抗原结合片段及其应用 | |
| WO2026041035A1 (zh) | 一种包含il-36r/il-23结合蛋白的药物组合物及其用途 | |
| WO2025223473A1 (zh) | 抗gdf-15抗体及其应用 |